Results 11 to 20 of about 411 (173)
Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer
Endometrial cancer is the most common malignancy of the female genital tract and its incidence is rising in parallel with the mounting prevalence of obesity. Early diagnosis has great potential to improve outcomes as treatment can be curative, especially
Kelechi Njoku +12 more
doaj +1 more source
Wearable electrochemical flexible biosensors: With the focus on affinity biosensors
Stretchable biosensors are emerging tools to monitor patients. Previous research results should be compared and classified to offer satisfactory solutions to challenges facing the ideation and development of stretchable biosensors.
Saeed Takaloo, Mahdi Moghimi Zand
doaj +1 more source
Immunotherapy for cancer is now a standard pillar in the armamentarium of treatments for many cancers. Immune checkpoint inhibitors, in particular, have resulted in significant therapeutic benefit and prolongation of survival in solid organ cancers, such
Michael D Green +8 more
doaj +1 more source
Advances in screening and diagnostic lab-on-chip tools for gynaecological cancers – a review
Gynaecological cancers are a major global health concern due to the lack of effective screening programmes for ovarian and endometrial cancer, for example, and variable access to vaccination and screening tests for cervical cancer in many countries ...
Sadeka Nujhat +4 more
doaj +1 more source
The ROBoCoP project is launched within the EU COST Action CA16113 “CliniMARK” aiming to increase the number of clinically validated biomarkers and focused on chronic obstructive pulmonary disease (COPD) biomarker development and validation.
I. Guseva Canu +10 more
doaj +1 more source
Multiplexed Prostate Cancer Companion Diagnostic Devices
Prostate cancer (PCa) remains one of the most prominent forms of cancer for men. Since the early 1990s, Prostate-Specific Antigen (PSA) has been a commonly recognized PCa-associated protein biomarker.
Josephine Aidoo-Brown +2 more
doaj +1 more source
Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative
Despite growing research efforts, no reliable biomarker currently exists for the diagnosis and prognosis of multiple system atrophy (MSA). Such biomarkers are urgently needed to improve diagnostic accuracy, prognostic guidance and also to serve as ...
Brice Laurens +14 more
doaj +1 more source
Point-of-Care Monitoring of Respiratory Diseases Using Lateral Flow Assay and CMOS Camera Reader
Objective: Respiratory disease is a rapidly growing global health issue that impacts the quality of living of tens of millions of people around the world.
Shasidran Raj +5 more
doaj +1 more source
Blood and cerebrospinal fluid (CSF) biomarkers are essential tools for the rapid diagnosis and monitoring of neurodegenerative diseases like Alzheimer's disease (AD). However, even minor variations in sample collection and storage procedures can significantly impact biomarker measurements, emphasizing the importance of standardized operating procedures.
Hyuk Sung Kwon +12 more
openaire +2 more sources
Isolation and Quantification of Extracellular DNA from Biofluids
Extracellular DNA is studied as a diagnostic biomarker, but also as a factor involved in the pathophysiology of several diseases due to its pro-inflammatory properties.
Ľubica Janovičová +3 more
doaj +1 more source

